Siemens introduces MR operation by remote
Siemens demonstrated hands-off imaging at the RSNA with a work in progress that turns control of an MR scanner over to remote operators. The goal behind Expert-I, which is pending FDA clearance, is to allow expert collaboration on challenging examinations regardless of how far away the expert may be.
Siemens demonstrated hands-off imaging at the RSNA with a work in progress that turns control of an MR scanner over to remote operators. The goal behind Expert-I, which is pending FDA clearance, is to allow expert collaboration on challenging examinations regardless of how far away the expert may be.
With the necessary software and a high-speed connection, experts can work an MR console from their PCs while patients are being scanned, according to the company. Patient set-up, sequences, and imaging data can be viewed in real-time.
Siemens demonstrated the capability in its exhibit booth utilizing a real-time link between the University of California-Los Angeles and Northwestern University in Chicago.
Other Siemens MR introductions include syngo Susceptibility Weighted Imaging (SWI), which promises to better visualize bleeding in stroke and brain trauma patients, contusions and shearing injuries, and minute intracranial vascular malformations. A body diffusion technique, called syngo REVEAL, helps differentiate lesions throughout the body, particularly malignant from benign ones. Syngo GRAPPA offers faster spine and cardiac imaging, with a small field-of-view to provide high spatial resolution.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
